0599 Pill - brown capsule/oblong
Pill with imprint 0599 is Brown, Capsule/Oblong and has been identified as Imatinib Mesylate 400 mg. It is supplied by Breckenridge Pharmaceutical, Inc.
Imatinib is used in the treatment of Chronic Myelogenous Leukemia; Chronic Eosinophilic Leukemia; Acute Lymphoblastic Leukemia; Dermatofibrosarcoma Protuberans; Gastrointestinal Stromal Tumor and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 400 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 0599
Imatinib Mesylate
- Imprint
- 0599
- Strength
- 400 mg
- Color
- Brown
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- BCR-ABL tyrosine kinase inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Breckenridge Pharmaceutical, Inc.
- Manufacturer
- Stason Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 51991-0377 (Discontinued)
Related images for "0599"
More about imatinib
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (45)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: BCR-ABL tyrosine kinase inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.